Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPCORITAMAB for B-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 63 adverse event reports in the FDA FAERS database where EPCORITAMAB was used for B-cell lymphoma.

Most Reported Side Effects for EPCORITAMAB

Side Effect Reports % Deaths Hosp.
Cytokine release syndrome 551 27.0% 66 507
Pyrexia 258 12.6% 51 234
Off label use 229 11.2% 69 182
Febrile neutropenia 219 10.7% 19 216
Pneumonia 154 7.6% 38 138
Covid-19 125 6.1% 25 108
Sepsis 106 5.2% 46 95
Hypotension 95 4.7% 31 86
Diffuse large b-cell lymphoma 86 4.2% 46 15
Neutropenia 84 4.1% 24 66
Diarrhoea 83 4.1% 9 78
Disease progression 79 3.9% 42 36
Immune effector cell-associated neurotoxicity syndrome 78 3.8% 34 47
C-reactive protein increased 75 3.7% 2 74
Thrombocytopenia 68 3.3% 24 57

Other Indications for EPCORITAMAB

Diffuse large b-cell lymphoma (624) Follicular lymphoma (319) Diffuse large b-cell lymphoma stage iv (311) Product used for unknown indication (189) Diffuse large b-cell lymphoma stage iii (143) Follicular lymphoma stage iv (110) Diffuse large b-cell lymphoma stage ii (71) Diffuse large b-cell lymphoma stage i (59) Richter's syndrome (51) Follicular lymphoma stage iii (40)

Other Drugs Used for B-cell lymphoma

RITUXIMAB (7,811) CYCLOPHOSPHAMIDE (4,766) VINCRISTINE (4,346) DOXORUBICIN (3,947) LENALIDOMIDE (3,474) PREDNISONE (2,561) BENDAMUSTINE (1,668) PREDNISOLONE (1,489) ETOPOSIDE (1,268) IDELALISIB (1,240)

Related Pages

EPCORITAMAB Full Profile All B-cell lymphoma Drugs EPCORITAMAB Demographics EPCORITAMAB Timeline